Under the Medicines, Poisons and Therapeutic Goods Regulation 2026, all activities involving Schedule 8 medicines and substances must be recorded in a drug register.
These Standards set out the requirements for electronic drug registers. Any electronic system used as a drug register for Schedule 8 medicines and substances must comply with these Standards.
The Electronic Drug Register Guideline supports the Standards by providing best practice information relating to the implementation and use of an electronic drug register.